Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
epygenix
Press Release
Jul 21, 2022
Epygenix Therapeutics to Participate in RW Baird's Biotech Discovery Series
Read More
Press Release
Jun 1, 2022
First Canadian Participant Dosed in ARGUS Trial, A Phase 2 Potentially Pivotal Study of EPX-100 Treatment of Dravet Syndrome
Read More
Press Release
May 23, 2022
Epygenix Therapeutics Announces Appointment of Dr. Lorianne Masuoka as Chief Medical Officer
Read More
First
Prev
1
Next
Last
